Orbytel Group, founded in 2009, specializes in providing AI-enabled, technology-driven solutions for managing and acting on scientific and clinical intelligence. The company's slogan, "Solutions to help teams manage and act on scientific and clinical intelligence," reflects its core focus. Orbytel Group's offerings include gathering scientific insights, identifying and engaging scientific expertise, performing comparative analyses of trial data, and translating this intelligence into investor-grade financial forecasts and narratives. Its client base comprises top-10 pharmaceutical companies globally, as well as various innovative rising firms, with a focus on R&D, Medical Affairs, Business Development, Commercial Development, and Marketing teams. The company operates within the AI, Information Technology, and Machine Learning industries. Currently, last investment details and investors information are not available.
There is no investment information
No recent news or press coverage available for Orbytel Group.